Chipmaker Advanced Micro Devices is cutting fiscal Q3 revenue guidance, and NPS Pharmaceuticals is popping after the FDA issued an upbeat preview of its short bowel syndrome drug Gattex, with CNBC's Amanda Drury and Brian Sullivan.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT